Antimicrobial Activity of the Marine Alkaloids, Clathrodin and Oroidin, and Their Synthetic Analogues

Marine organisms produce secondary metabolites that may be valuable for the development of novel drug leads as such and can also provide structural scaffolds for the design and synthesis of novel bioactive compounds. The marine alkaloids, clathrodin and oroidin, which were originally isolated from sponges of the genus, Agelas, were prepared and evaluated for their antimicrobial activity against three bacterial strains (Enterococcus faecalis, Staphylococcus aureus and Escherichia coli) and one fungal strain (Candida albicans), and oroidin was found to possess promising Gram-positive antibacterial activity. Using oroidin as a scaffold, 34 new analogues were designed, prepared and screened for their antimicrobial properties. Of these compounds, 12 exhibited >80% inhibition of the growth of at least one microorganism at a concentration of 50 µM. The most active derivative was found to be 4-phenyl-2-aminoimidazole 6h, which exhibited MIC90 (minimum inhibitory concentration) values of 12.5 µM against the Gram-positive bacteria and 50 µM against E. coli. The selectivity index between S. aureus and mammalian cells, which is important to consider in the evaluation of a compound’s potential as an antimicrobial lead, was found to be 2.9 for compound 6h.

[1]  C. Ireland,et al.  A study on the mechanism of action of sceptrin, an antimicrobial agent isolated from the South Pacific sponge Agelas mauritiana. , 1993, The Journal of antimicrobial chemotherapy.

[2]  S. Webber,et al.  A Simple and Practical Synthesis of 2‐Aminoimidazoles. , 1995 .

[3]  P. Potier,et al.  Sponge's Molecular Diversity Through the Ambivalent Reactivity of 2‐Aminoimidazole: A Universal Chemical Pathway to the Oroidin‐Based Pyrrole‐Imidazole Alkaloids and Their Palau'amine Congeners , 2001 .

[4]  Mary Jane Ferraro,et al.  Performance standards for antimicrobial susceptibility testing : twelfth informational supplement , 2002 .

[5]  R. French,et al.  Marine Toxins That Target Voltage-gated Sodium Channels , 2006, Marine Drugs.

[6]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[7]  P. Tonge,et al.  Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli. , 2007, Bioorganic & Medicinal Chemistry.

[8]  J. Frère,et al.  Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. , 2008, The Lancet. Infectious diseases.

[9]  C. Melander,et al.  Effects of N-pyrrole substitution on the anti-biofilm activities of oroidin derivatives against Acinetobacter baumannii. , 2008, Bioorganic & medicinal chemistry letters.

[10]  C. Melander,et al.  A 2-aminobenzimidazole that inhibits and disperses gram-positive biofilms through a zinc-dependent mechanism. , 2009, Journal of the American Chemical Society.

[11]  C. Piutti,et al.  A Submarine Journey: The Pyrrole-Imidazole Alkaloids † , 2009, Marine drugs.

[12]  Sean D. Stowe,et al.  Amide isosteres of oroidin: assessment of antibiofilm activity and C. elegans toxicity. , 2009, Journal of medicinal chemistry.

[13]  C. Melander,et al.  Antibiofilm activity of a diverse oroidin library generated through reductive acylation. , 2009, The Journal of organic chemistry.

[14]  L. M. Lima,et al.  Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides. , 2009, Bioorganic & medicinal chemistry.

[15]  J. Cavanagh,et al.  Synergistic Effects between Conventional Antibiotics and 2-Aminoimidazole-Derived Antibiofilm Agents , 2010, Antimicrobial Agents and Chemotherapy.

[16]  C. Melander,et al.  The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii. , 2010, Bioorganic & medicinal chemistry.

[17]  D. Taşdemir,et al.  Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites , 2010, Marine drugs.

[18]  N. Boughalleb,et al.  Antifungal effects of secondary metabolites isolated from marine organisms collected from the Tunisian coast , 2010 .

[19]  C. Melander,et al.  Identification of aryl 2-aminoimidazoles as biofilm inhibitors in Gram-negative bacteria. , 2010, Bioorganic & medicinal chemistry letters.

[20]  Daniel. C. Whitehead,et al.  Synthesis and biological evaluation of 2-aminoimidazole/carbamate hybrid anti-biofilm and anti-microbial agents. , 2011, Bioorganic & medicinal chemistry letters.

[21]  S. D. De Keersmaecker,et al.  Structure-activity relationship of 4(5)-aryl-2-amino-1H-imidazoles, N1-substituted 2-aminoimidazoles and imidazo[1,2-a]pyrimidinium salts as inhibitors of biofilm formation by Salmonella typhimurium and Pseudomonas aeruginosa. , 2011, Journal of medicinal chemistry.

[22]  Sean D. Stowe,et al.  Anti-Biofilm Compounds Derived from Marine Sponges , 2011, Marine drugs.

[23]  D. Romo,et al.  Biosynthesis, Asymmetric Synthesis, and Pharmacology, Including Cellular Targets, of the Pyrrole‐2‐aminoimidazole Marine Alkaloids , 2011 .

[24]  L. Silver.  Challenges of Antibacterial Discovery , 2011, Clinical Microbiology Reviews.

[25]  E. Martis,et al.  Novel Antibiotics from Marine Sources , 2011 .

[26]  S. D. De Keersmaecker,et al.  Structure-activity relationship of 2-hydroxy-2-aryl-2,3-dihydro-imidazo[1,2-a]pyrimidinium salts and 2N-substituted 4(5)-aryl-2-amino-1H-imidazoles as inhibitors of biofilm formation by Salmonella Typhimurium and Pseudomonas aeruginosa. , 2011, Bioorganic & medicinal chemistry.

[27]  A facile synthesis of 1,5-disubstituted-2-aminoimidazoles: antibiotic activity of a first generation library. , 2011, Bioorganic & medicinal chemistry letters.

[28]  Sean D. Stowe,et al.  Identification of BfmR, a response regulator involved in biofilm development, as a target for a 2-Aminoimidazole-based antibiofilm agent. , 2012, Biochemistry.

[29]  M. Toleman,et al.  The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. , 2012, The Journal of antimicrobial chemotherapy.

[30]  U. Theuretzbacher.  Accelerating resistance, inadequate antibacterial drug pipelines and international responses. , 2012, International journal of antimicrobial agents.

[31]  D. Madge,et al.  Substituted 4-phenyl-2-aminoimidazoles and 4-phenyl-4,5-dihydro-2-aminoimidazoles as voltage-gated sodium channel modulators. , 2014, European journal of medicinal chemistry.

[32]  U. Pennsylvania,et al.  Clinical and Laboratory Standards Institute , 2019, Springer Reference Medizin.